Delivery Order SPE2DB22D3301-SPE2DB25FX5BG
Award Date
11/6/24
Potential Completion Date
11/29/24
Potential Value
$80K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,658.73 firm-fixed-price contract provides for the delivery of ANDEXXA 200 MG vials, a specialized medication. The contract has a completion date of November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division for the delivery of 4564433758 ANDEXXA 200 MG VIALS. The contract has a firm fixed price ceiling value of $33,293.65 and a completion date of May 20, 2024. This is a delivery order contract type with no set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, has been awarded this order as part of its Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,888.85, is for the delivery of 4566586927 ANDEXXA 200MG VIALS 4S. This is a Firm Fixed Price Delivery Order contract with a performance period through December 4, 2024. The contract is not designated with a set-aside requirement. AmerisourceBergen Drug Corp holds a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,931.53, is for the delivery of ANDEXXA 200 MG VIALS and has an ultimate completion date of April 2, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. government has awarded a delivery order contract worth $15,050.28 to Amerisourcebergen Drug Corp's Corporate Office Division to provide the pharmaceutical product ANDEXXA 200 MG VIALS. This contract has no set-aside designation and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen supplies a comprehensive range of...
The U.S. federal government awarded a delivery order contract valued at $6,658.72 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of ANDEXXA 200 MG VIALS, a pharmaceutical product. This contract is not set aside for any particular business type. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This federal contract award is for the delivery of ANDEXXA 200 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $8,391.55. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ANDEXXA 200 MG VIALS, a medical product, with a ceiling value of $6,931.53 and a period of performance through April 11, 2025. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,376.62 firm fixed-price contract has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,028.56 firm-fixed-price contract will run through February 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...